SGYP
T. Rowe Price Associates’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-50,707
| Closed | -$147K | – | 2631 |
|
|
2017
Q3 | $147K | Buy |
50,707
+100
| +0.2% | +$290 | ﹤0.01% | 2444 |
|
|
2017
Q2 | $225K | Buy |
50,607
+7,400
| +17% | +$32.9K | ﹤0.01% | 2332 |
|
|
2017
Q1 | $201K | Buy |
43,207
+100
| +0.2% | +$465 | ﹤0.01% | 2396 |
|
|
2016
Q4 | $263K | Hold |
43,107
| – | – | ﹤0.01% | 2292 |
|
|
2016
Q3 | $238K | Sell |
43,107
-45,493
| -51% | -$251K | ﹤0.01% | 2301 |
|
|
2016
Q2 | $337K | Buy |
88,600
+37,000
| +72% | +$141K | ﹤0.01% | 2118 |
|
|
2016
Q1 | $142K | Buy |
51,600
+15,900
| +45% | +$43.8K | ﹤0.01% | 2363 |
|
|
2015
Q4 | $202K | Sell |
35,700
-11,300
| -24% | -$63.9K | ﹤0.01% | 2300 |
|
|
2015
Q3 | $249K | Hold |
47,000
| – | – | ﹤0.01% | 2208 |
|
|
2015
Q2 | $390K | Hold |
47,000
| – | – | ﹤0.01% | 2097 |
|
|
2015
Q1 | $217K | Hold |
47,000
| – | – | ﹤0.01% | 2326 |
|
|
2014
Q4 | $143K | Sell |
47,000
-23,000
| -33% | -$70K | ﹤0.01% | 2426 |
|
|
2014
Q3 | $195K | Buy |
70,000
+30,200
| +76% | +$84.1K | ﹤0.01% | 2352 |
|
|
2014
Q2 | $162K | Buy |
39,800
+18,300
| +85% | +$74.5K | ﹤0.01% | 2402 |
|
|
2014
Q1 | $114K | Buy |
+21,500
| New | +$114K | ﹤0.01% | 2417 |
|
|
2013
Q4 | – | Sell |
-25,000
| Closed | -$114K | – | 2526 |
|
|
2013
Q3 | $114K | Buy |
25,000
+3,000
| +14% | +$13.7K | ﹤0.01% | 2375 |
|
|
2013
Q2 | $95K | Buy |
+22,000
| New | +$95K | ﹤0.01% | 2349 |
|